In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACOs Get In Gear, Accelerating Biopharma’s Value Imperative

Executive Summary

Pharmaceutical companies have been reluctant to discuss their accountable care organization strategies, but the 32 “Pioneer” ACOs created this year could impact the way pharma develops and commercializes its drugs, and their influence will be felt well beyond their current Medicare remit.

Advertisement

Related Content

Germany’s Pricing Revolution: Why The World Should Be Watching
Germany’s Pricing Revolution: Why The World Should Be Watching
How Incentives Are Shaping Medtech’s Future
Final Medicare ACO Rule Rejects Pharma Industry Requests For Rx Access Protections
Pfizer’s Xalkori Joins The Six-Figure Oncology Drug Club
WellPoint Plans To Seek Pharma Partners For Outcomes-Based Contracting: An Interview With WellPoint's Brian Sweet

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel